Patents by Inventor Birgitte P. S. Jacky

Birgitte P. S. Jacky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
    Publication number: 20120149103
    Abstract: The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
    Type: Application
    Filed: December 28, 2011
    Publication date: June 14, 2012
    Inventors: Hong Zhu, Joanne Wang, Birgitte P.S. Jacky, D. Dianne Hodges, Fernandez-Salas Ester
  • Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
    Publication number: 20120149106
    Abstract: The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
    Type: Application
    Filed: December 28, 2011
    Publication date: June 14, 2012
    Inventors: Hong Zhu, Joanne Wang, Birgitte P.S. Jacky, D. Dianne Hodges, Fernandez-Salas Ester
  • Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
    Publication number: 20120149105
    Abstract: The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
    Type: Application
    Filed: December 28, 2011
    Publication date: June 14, 2012
    Inventors: Hong Zhu, Joanne Wang, Birgitte P.S. Jacky, D. Dianne Hodges, Fernandez-Salas Ester
  • Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
    Publication number: 20120149104
    Abstract: The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
    Type: Application
    Filed: December 28, 2011
    Publication date: June 14, 2012
    Inventors: Hong Zhu, Joanne Wang, Birgitte P.S. Jacky, D. Dianne Hodges, Fernandez-Salas Ester
  • Methods of Treating Cancer Using Tachykinin Retargeted Endopepidases
    Publication number: 20110110911
    Abstract: The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
    Type: Application
    Filed: August 16, 2010
    Publication date: May 12, 2011
    Inventors: Birgitte P.S. Jacky, Patton E. Garay, Yanira Molina, Dean G. Stathakis, Joseph Francis, Kei Roger Aoki, Ester Fernandez-Salas
  • METHODS OF TREATING CANCER USING NEUROTROPHIN RETARGETED ENDOPEPTIDASES
    Publication number: 20110070215
    Abstract: The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
    Type: Application
    Filed: August 16, 2010
    Publication date: March 24, 2011
    Inventors: Birgitte P.S. Jacky, Patton E. Garay, Yanira Molina, Dean G. Stathakis, Joseph Francis, Kei Roger Aoki, Ester Fernandez-Salas
  • Methods of Treating Cancer Using Galanin Retargeted Endopepidases
    Publication number: 20110070211
    Abstract: The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
    Type: Application
    Filed: August 13, 2010
    Publication date: March 24, 2011
    Inventors: BIRGITTE P.S. JACKY, PATTON E. GARAY, YANIRA MOLINA, DEAN G. STATHAKIS, JOSEPH FRANCIS, KEI ROGER AOKI, ESTER FERNANDEZ-SALAS
  • Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases
    Publication number: 20110070212
    Abstract: The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
    Type: Application
    Filed: August 16, 2010
    Publication date: March 24, 2011
    Inventors: Birgitte P.S. Jacky, Patton E. Garay, Yanira Molina, Dean G. Stathakis, Joseph Francis, Kei Roger Aoki, Ester Fernandez-Salas
  • Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases
    Publication number: 20110070186
    Abstract: The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
    Type: Application
    Filed: August 16, 2010
    Publication date: March 24, 2011
    Inventors: Birgitte P.S. Jacky, Patton E. Garay, Yanira Molina, Dean G. Stathakis, Joseph Francis, Kei Roger Aoki, Ester Fernandez-Salas
  • Methods of Treating Cancer Using Opioid Retargeted Endopepidases
    Publication number: 20110064713
    Abstract: The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
    Type: Application
    Filed: August 13, 2010
    Publication date: March 17, 2011
    Inventors: Birgitte P.S. Jacky, Patton E. Garay, Yanira Molina, Dean G. Stathakis, Joseph Francis, Kei Roger Aoki, Ester Fernandez-Salas
  • CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
    Publication number: 20100233802
    Abstract: The present specification discloses clonal cell lines susceptible to BoNT/A intoxication, methods of producing such clonal cell lines, and methods of detecting Botulinum toxin serotype A activity using such clonal cell lines.
    Type: Application
    Filed: March 12, 2010
    Publication date: September 16, 2010
    Inventors: Hong Zhu, Joanne Wang, Birgitte P.S. Jacky, D. Dianne Hodges, Ester Fernandez-Salas
  • BOTULINUM TOXIN SCREENING ASSAYS
    Publication number: 20090263836
    Abstract: Methods for detecting BoNT/A activity in a sample, methods for screening molecules able to compete with BoNT/A receptor binding, methods for reducing BoNT/A activity in a human and methods of marketing a neurotoxin capable of selectively binding to a FGFR2, a FGFR3, a SV2, or any combination thereof, to a governmental or regional regulatory authority.
    Type: Application
    Filed: May 20, 2009
    Publication date: October 22, 2009
    Applicant: ALLERGAN, INC.
    Inventors: ESTER FERNANDEZ-SALAS, Birgitte P.S. Jacky, Patton E. Garay, Kei Roger Aoki